Home
About
Overview
Sharing Data
ORCID
Help
History (5)
Apathy in Parkinson disease: Why we should care.
Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR): a multicentre, open-label, phase 1 trial.
Behavior Rating Scale
Evaluating interpersonal discrimination and depressive symptoms as partial mediators of the effects of education on cognition: Evidence from the Study of Healthy Aging in African Americans (STAR).
Post-Mortem Studies of Neurturin Gene Therapy for Parkinson's Disease: Two Subjects with 10?Years CERE120 Delivery.
See All 5 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Apathy in Parkinson disease: Why we should care.
Apathy in Parkinson disease: Why we should care. Neurology. 2020 11 17; 95(20):893-894.
View in:
PubMed
subject areas
Apathy
Depression
Disruptive, Impulse Control, and Conduct Disorders
Humans
Parkinson Disease